Sole Source- FilmArray and BFDf Reagents Nov 2024.pdf
PDF 191 KB Posted
- Solicitation number
- 25-482DPH-OFCDI-B-46845
- Issued by
- Illinois
About this file
This document is a sole source notification letter from BioFire Defense, LLC and bioMerieux, Inc. addressing the exclusive provision of BIOFIRE FILMARRAY Systems and Reagents. The letter confirms that these companies are the sole providers of BIOFIRE FILMARRAY 2.0 and BIOFIRE FILMARRAY Torch Systems in the United States, including associated services, maintenance, warranties, software, and system-specific reagents. The systems are specialized diagnostic instruments capable of simultaneously detecting and identifying multiple pathogens within approximately one hour, requiring minimal training and hands-on time.
The notification details specific reagent kits exclusively provided by BioFire Defense, LLC, including COVID-19 tests, BioThreat Panels, Global Fever Panels, Food & Water Panels, and various specialized pathogen detection kits. The company holds multiple US and foreign patents protecting their unique technology, which differentiates their products in the market by offering rapid, comprehensive pathogen identification across various test panels. The letter serves as an official communication to inform potential users and procurement entities about the exclusive nature of their diagnostic testing systems and reagent kits.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
04-Nov-2024
RE: Sole Source for BIOFIRE® FILMARRAY® Systems and Reagents
To Whom it May Concern, BioFire Defense, LLC and its affiliate bioMérieux, Inc. are the sole providers of the BIOFIRE® FILMARRAY® 2.0 and BIOFIRE® FILMARRAY® Torch Systems including service, maintenance, extended warranties, software and the system specific reagents in the United States. This letter is to serve as a sole source notification for these items.
The BioFire instruments and accompanying reagent kits, multiplexed nucleic acid tests, can simultaneously detect and identify multiple pathogens in about one hour. The device detects pathogen specific nucleic acids collected from samples specific to the test panel and its intended use. The easy-to-use system requires little training and only minutes of hands-on time to complete a test. These attributes make it unique in the market. BioFire and its affiliates are the sole developers and hold several US and foreign patents and patents pending protecting this technology.
Furthermore, BioFire Defense, LLC is the sole provider of the following reagent kits:
Part Number Description 423744 or 423745 BioFire COVID-19 Test RFIT-ASY-0094 BioThreat Panel RFIT-ASY-0122 BioThreat-E Test DFA2-ASY-0003 Global Fever Panel – RUO NGDS-ASY-0016 Food & Water Panel DFA2-ASY-0004 BioFire Global Fever Panel v2.1 DFA2-ASY-0018 BioFire Global Fever Special
Pathogens Panel NGDS-ASY-0007 NGDS Warrior Panel NGDS-ASY-0017 NGDS Sentinel Panel
If you have any further questions, feel free to contact me.
Sincerely, Ryan Gregerson Associate Director Sales and Marketing
File details come from the government source that posted it. Updated .